Trial intelligence / Profile preview

Low Dose Magnesium Sulphate vs Pritchard Regimen in Severe Preeclampsia/Eclampsia

NCT04501289Completed

Start
May 2017
Primary completion
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of magnesium sulfate in preeclampsia and eclampsia (2 arms). Primary endpoint: Occurrence of Convulsion at 24 hours. Started May 2017; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

preeclampsiaeclampsia

Beyond the preview

Go deeper on NCT04501289.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04501289.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call